Assertio Holdings Inc - ESG Rating & Company Profile powered by AI
The Disclosure rating covers 17 United Nations SDGs including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Life on Land'. This analysis of Assertio Holdings Inc is assembled by All Street Sevva using proprietary AI. Other corporations in the rating industry group for Assertio Holdings Inc are shownin the table.
Assertio Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 4.0, social score of 1.3 and governance score of 3.4.
2.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1800 | Wuhan Hiteck Biological Pharma Co Ltd | 3.0 | Medium |
| 1800 | Zhejiang Jingxin Pharmaceutical Co Ltd | 3.0 | Medium |
| 1836 | Assertio Holdings Inc | 2.9 | Medium |
| 1836 | Aarey Drugs and Pharmaceuticals Ltd | 2.9 | Medium |
| 1836 | Alpha Teknova Inc | 2.9 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Assertio Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Assertio Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Assertio Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Assertio Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Assertio Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Assertio Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Assertio Holdings Inc offer flexible work?
Sign up for free to unlockDoes Assertio Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Assertio Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Assertio Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Assertio Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Assertio Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Assertio Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Assertio Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Assertio Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Assertio Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Assertio Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Assertio Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Assertio Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Assertio Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Assertio Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Assertio Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Assertio Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Assertio Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Assertio Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Assertio Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Assertio Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Assertio Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Assertio Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Assertio Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Assertio Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Assertio Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Assertio Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Assertio Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Assertio Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Assertio Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Assertio Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company's pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.